From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging

Background:. Prostate cancer (PCa) diagnosis has historically relied on prostate-specific antigen (PSA) testing. Although PSA screening significantly reduces mortality rates, it is limited by its low specificity and the risk of overdiagnosis and overtreatment. These limitations highlight the need fo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Helena Margot Flôres Soares da Silva, Juan Gómez Rivas, Paula Mata Déniz, María Jesús Marugan, Claudia González-Santander, Lorena Fernández Montarroso, Isabel Galante, Jesús Moreno Sierra
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Health 2026-05-01
Col·lecció:	Current Urology
Accés en línia:	http://journals.lww.com/10.1097/CU9.0000000000000326
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!